Erythrophagocytosis in de novo-Philadelphia-positive acute leukemia of ambiguous lineage Haematologica 2006 Ortuño FJ, Castilla C, Moreno MJ, del Mar Osma M, González M, Vicente V. 91(8 Suppl):ECRe114-e116. FI: 6.416 (Q1) Thalidomide in multiple myeloma García-Sanz R. Expert Opinion on Pharmacotherapy 7(2):195-213. FI: 2.018 (Q3) Update on treatment recommendations from the Third International Workshop on Waldenstrom's Macroglobulinemia Treon SP, Gertz MA, Dimopoulos M, Anagnostopoulos A, Blade J, Branagan AR, García-Sanz R, Johnson S, Kimby E, Leblond V, Fermand JP, Maloney DG, Merlini G, Morel P, Morra E, Nichols G, Ocio EM, Owen R, Stone MJ. Blood 107(9):3442-6. FI: 10.555 (Q1) Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's Macroglobulinemia Kimby E, Treon SP, Anagnostopoulos A, Dimopoulos M, García-Sanz R, Gertz MA, Johnson S, LeBlond V, Fermand JP, Maloney DG, Merlini G, Morel P, Morra E, Nichols G, Ocio EM, Owen R, Stone M, Blade J. Clinical Lymphoma & Myeloma 6(5):380-3. FI: 1.130 (Q4) Lineage involvement in chronic myeloid leukaemia: comparison between MBCR/ABL and mBCR/ABL cases Primo D, Sanchez ML, Espinosa AB, Tabernero MD, Rasillo A, Sayagues JM, González M, Hernandez JM, Orfao A. British Journal of Haematology 132:736-9. FI: 4.597 (Q1) TCR gammadelta large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRgammadelta. T-cells Sandberg Y, Almeida J, González M, Lima M, Barcena P, Szczepanski T, van Gastel-Mol EJ, Wind H, Balanzategui A, van Dongen JJ, Miguel JF, Orfao A, Langerak AW. Leukemia 20:505-13. FI: 8.296 (Q1) Application of self-quenched JH consensus primers for real-time quantitative PCR of IGH Gene to minimal residual disease evaluation in multiple myeloma Martinez-Lopez J, Martinez-Sanchez P, García-Sanz R, Sarasquete ME, Ayala R, Gonzalez M, Bautista JM, Gonzalez D, San Miguel J, Garcia-Effron G, Lahuerta JJ. Journal of Molecular Diagnostics 8(3):364-70. FI: 3.413 (Q1) Heterogeneity of neoplastic cells in B-cell chronic lymphoproliferative disorders: biclonality versus intraclonal evolution of a single tumor cell clone - Sanchez ML, Almeida J, Lopez A, Sayagues JM, Rasillo A, Sarasquete ME , Balanzategui A, Tabernero MD, Diaz-Mediavilla J, Barrachina C, Paiva A, González M, San Miguel JF, Orfao A. Haematologica 91:331-9. FI: 6.416 (Q1) Impact of bcr/abl gene expression on the proliferative rate of different subpopulations of hematopoietic cells in chronic myeloid leukaemia Primo D, Flores J, Quijano S, Sanchez ML, Sarasquete ME, del Pino-Montes J, Gaarder PI, Gonzalez M, Orfao A. British Journal of Haematology 135:43-51. FI: 4.597 (Q1) The association of increased p14ARF/p16INK4a and p15INK4a gene expression with proliferative activity and the clinical course of multiple myeloma Sarasquete ME, García-Sanz R, Armellini A, Fuertes M, Martín-Jiménez P, Sierra M, Chillón MC, Alcoceba M, Balanzategui A, Ortega F, Hernández JM, Sureda A, Palomera L, González M and San Miguel JF. Haematologica 91: 1553-1556. FI: 6.416 (Q1)
|
